Efficacy and safety of saxagliptin 5 mg once-daily therapy in elderly patients with type 2 diabetes mellitus

被引：0
|
作者：
Maheux, P. [1 ]
Doucet, J. [2 ]
Allen, E. [3 ]
Ravichandran, S. [3 ]
Harris, S.
Chen, R. [3 ]
Brulle, C. [4 ]
机构：
[1] AstraZeneca ISMO Europe, Brussels, Belgium
[2] CHU Rouen, Rouen, France
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Bristol Myers Squibb EMEA, Paris, France
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
766
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [41] Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
    Perl, Shira
    Cook, William
    Wei, Cheryl
    Iqbal, Nayyar
    Hirshberg, Boaz
    DIABETES THERAPY, 2016, 7 (03) : 527 - 535
  • [42] Efficacy and safety of lixisenatide once-daily versus exenatide twice-daily in patients with type 2 diabetes insufficiently controlled on metformin (GetGoal-X)
    Rosenstock, J.
    Raccah, D.
    Koranyi, L.
    Maffei, L.
    Boka, G.
    Miossec, P.
    Gerich, J. E.
    DIABETOLOGIA, 2011, 54 : S317 - S318
  • [43] The efficacy and safety of acarbose in the treatment of type 2 diabetes mellitus in elderly patients.
    Chiasson, JL
    Josse, RG
    Dorman, JM
    Gerstein, HC
    Lau, D
    Leiter, LA
    Maheux, P
    Meneilly, GS
    Murphy, L
    Rodger, NW
    Ross, SA
    Ryan, E
    Yale, JF
    Wolever, TMS
    Haller, T
    Elias, I
    DIABETOLOGIA, 1999, 42 : A223 - A223
  • [44] Detemir as a once-daily basal insulin in type 2 diabetes
    Nelson, Scott E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
  • [45] Efficacy and Safety of Saxagliptin in Patients with Type 2 Diabetes: Outcomes by Race and Ethnicity
    Barrett, Yu Chen
    Minervini, Gianmaria
    Chen, Hungta
    Ghannam, Ameen
    DIABETES, 2015, 64 : A323 - A323
  • [46] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia
    Fukuda, Masahiro
    Doi, Kunihiro
    Sugawara, Masahiro
    Mochizuki, Koichi
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 383 - 391
  • [47] Efficacy and Safety of Once Daily Remogliflozin Etabonate for the Treatment of Type 2 Diabetes
    Sykes, Andy
    Wilkison, William O.
    Kler, Lata
    Kemp, Gail
    Almond, Steve
    Dobbins, Robert L.
    O'Connor-Semmes, Robin
    DIABETES, 2014, 63 : A287 - A287
  • [48] Impact of Age on the Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Insulin in Type 2 Diabetes (ONWARDS 1-5)
    Vianna, Andre G. D.
    Desouza, Cyrus
    Laugesen, Christian
    Marques, Mariana Fragao
    Nielsen, Pernille Hojlund
    Shaikh, Shehla S.
    Lingvay, Ildiko
    DIABETES, 2024, 73
  • [49] EFFECT OF AGE ON EFFICACY AND SAFETY OF ONCE-DAILY UMECLIDINIUM IN PATIENTS WITH COPD
    Soule, Tedi
    Caveney, Scott
    Tombs, Lee
    Naya, Ian
    Boucot, Isabelle
    CHEST, 2018, 154 (04) : 750A - 750A
  • [50] Efficacy and safety of once-daily amlodipine in patients with stable angina pectoris
    Haringer, E
    SauerbreyWullkopf, N
    MEDIZINISCHE WELT, 1996, 47 (04): : 175 - 180
12345